Yahoo Web Search

Search results

1. • Q1 2024 Viridian Therapeutics Inc Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 1 month ago

     Participants Louisa Stone; Manager, Investor Relations; Viridian Therapeutics Inc Scott Myers; Chief Executive Officer, President; Viridian Therapeutics Inc Thomas Ciulla; Chief Medical Officer ...

2. • Viridian Therapeutics Inc (VRDN) Q1 2024 Earnings Call Transcript Highlights: Strategic ...

     GuruFocus.com via Yahoo Finance· 1 month ago

     Cash, Cash Equivalents, and Short-term Investments: $613 million Cash Runway: Extended into the second half of 2026 Enrollment in THRIVE Trial: Exceeded target with 113 patients Expected Top-line ...